Search

Your search keyword '"Antibodies, Antinuclear immunology"' showing total 389 results

Search Constraints

Start Over You searched for: Descriptor "Antibodies, Antinuclear immunology" Remove constraint Descriptor: "Antibodies, Antinuclear immunology" Topic autoimmune diseases Remove constraint Topic: autoimmune diseases
389 results on '"Antibodies, Antinuclear immunology"'

Search Results

1. SARS-CoV-2 induced vitamin D deficiency and psychological stress: a manifestation of autoimmune disease onset.

2. Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies.

3. A TNIP1-driven systemic autoimmune disorder with elevated IgG4.

4. ANA-specific antibodies, ANA patterns, anti-ds-DNA results, and clinical diagnosis: a laboratory and clinical audit.

5. Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individuals.

6. Interkit Reproducibility of the Indirect Immunofluorescence Assay on HEp-2 Cells Depends on the Immunofluorescence Reactivity Intensity and Pattern.

7. How to report the antinuclear antibodies (anti-cell antibodies) test on HEp-2 cells: guidelines from the ICAP initiative.

8. Non-organ-specific autoimmunity in adult 47,XXY Klinefelter patients and higher-grade X-chromosome aneuploidies.

9. Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening.

10. Uncommon antinuclear antibody patterns as diagnostic indicators.

11. Prevalence of anti-dense fine speckled 70 antibodies in healthy individuals and patients with antinuclear antibody-associated autoimmune rheumatic diseases in Japan.

12. Identification of a unique anti-Ro60 subset with restricted serological and molecular profiles.

13. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases.

14. Case report of COVID-19 in an elderly patient: could SARS-CoV2 trigger myositis?

15. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment.

16. Prediction of outcome in fetal autoimmune complete heart block.

17. Evaluation of the Automated Indirect Immunofluorescence Test for Antinuclear Antibodies.

18. A multi-centre study for standardization of antinuclear antibody indirect immunofluorescence screening with automated system.

19. Pediatric Acute-Onset Neuropsychiatric Syndrome and Catatonia: A Case Report.

20. The challenges of primary biliary cholangitis: What is new and what needs to be done.

21. Autoantibodies to mRNA processing pathways (glycine and tryptophan-rich bodies antibodies): prevalence and clinical utility in a South Australian cohort.

22. Cellular aging over 13 years associated with incident antinuclear antibody positivity in the Baltimore Longitudinal Study of Aging.

23. T Cell Dysregulation in Non-silicotic Silica Exposed Workers: A Step Toward Immune Tolerance Breakdown.

24. Harmonization of clinical interpretation of antinuclear antibody test results by solid phase assay and by indirect immunofluorescence through likelihood ratios.

25. Recurrent post-partum rhombencephalitis associated with anti-centromere antibody: a case report.

26. Epidemiological survey of antinuclear antibodies in healthy population and analysis of clinical characteristics of positive population.

27. Professional Insights from a Pioneer in Autoimmune Disease Testing: The Future of Antinuclear/Anticellular Antibody Testing.

28. Mass cytometry reveals an impairment of B cell homeostasis in anti-synthetase syndrome.

29. [Is autoimmune cholangitis-anti-mitochondrial antibody-negative primary biliary cholangitis still an independent disease?]

30. Diagnostic Utility of Separate Anti-Ro60 and Anti-Ro52/TRIM21 Antibody Detection in Autoimmune Diseases.

31. Rare diseases that mimic Systemic Lupus Erythematosus (Lupus mimickers).

32. Initial presentation determines clinical entity in patients with anti-centromere antibody positivity.

33. The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic disease.

34. The clinical significance of borderline results of the Elia CTD Screen assay.

35. Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view?

36. Antinuclear antibody profiling in uveitis.

37. The importance of detecting anti-DFS70 in routine clinical practice: comparison of different care settings.

38. CD38 protein deficiency induces autoimmune characteristics and its activation enhances IL-10 production by regulatory B cells.

39. ILF2 and ILF3 are autoantigens in canine systemic autoimmune disease.

40. Prevalence and Clinical Significance of Anti-DFS70 in Antinuclear Antibody (ANA)-positive Patients Undergoing Routine ANA Testing in a New Zealand Public Hospital.

41. Clinicopathologic significance of in vivo antinuclear autoantibodies in oral mucosal biopsies.

42. Regulatory T cell deficient scurfy mice exhibit a Th2/M2-like inflammatory response in the skin.

43. Serological and morphological prognostic factors in patients with interstitial pneumonia with autoimmune features.

44. Challenges in the Standardization of Autoantibody Testing: a Comprehensive Review.

45. High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block.

46. Lack of evidence for post-vaccine onset of autoimmune/lymphoproliferative disorders, during a nine-month follow-up in multiply vaccinated Italian military personnel.

47. Chikungunya virus and autoimmunity.

48. Autoantibodies persist in relatives to systemic lupus erythematosus patients during 12 years follow-up.

49. The Clinical Relevance of Anti-DFS70 Autoantibodies.

50. Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosis.

Catalog

Books, media, physical & digital resources